SCHEMBL19373370

SCHEMBL19373370

Cc1cnc(-c2ccccc2C)cc1CC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 14/20 0.42
CYP2C19 P33261 10/20 0.42
CYP2D6 P10635 8/20 0.42
CYP3A4 P08684 8/20 0.42
CLK4 Q9HAZ1 7/20 0.42
ALDH1A1 P00352 5/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 2/20 0.42
TSHR P16473 4/20 0.40
MAPK1 P28482 4/20 0.40
TP53 P04637 2/20 0.40
HIF1A Q16665 2/20 0.40
IDO1 P14902 1/20 0.39
METAP2 P50579 1/20 0.39
LMNA P02545 3/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25497415 0.91 CYP1A2 (0.42) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL25983007 0.89 ALOX5AP (0.44) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL23189495 0.88 CYP1A2 (0.42) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL18729501 0.87 CYP1A2 (0.39) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL25071731 0.84 CYP1A2 (0.38) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL25071722 0.83 ALPL (0.35) CYP1A2CYP2C19CYP2D6CYP3A4ALDH1A1
SCHEMBL18730284 0.83 LDHA (0.46) CYP3A4ALDH1A1IDO1MEN1KMT2A
SCHEMBL24851613 0.82 CYP1A2 (0.45) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL27140488 0.81 ADORA3 (0.38) CYP3A4NPC1RAB9ASMN1; SMN2ALOX5AP
SCHEMBL24523589 0.81 AAK1 (0.37) ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054166-A1 COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-23 US disclosed
EP-3220439-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2017-09-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230054166-A1 COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE L1CAM, INF2, LSM12 CYP1A2 1171/4885CYP2C19 1311/4885CYP2D6 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.